Dr. David E. Zepeda Reyes

Dr. David E. Zepeda Reyes
  • Speciality Dermatologist and clinical research
  • Training With over 15 years of experience as a Dermatologist and Principal Investigator, I have successfully led my clinic and research center in conducting clinical trials across various medical specialties, ensuring the integrity and accuracy of the obtained data. My leadership has been crucial in coordinating multidisciplinary teams, guaranteeing the highest ethical and regulatory standards. I have actively contributed to publishing results in scientific journals. National and international speaker. I am committed to excellence and innovation in clinical research, continuously seeking opportunities for professional development and contributing to the advancement of medical knowledge.
  • know more <a class="buttonDowloads" href="https://carusv.com/blog/doctor/dr-david-e-zepeda-reyes/" rel="noopener"> <span class="button__text">Profile</span> <span class="button__icon">GO</span> </a>

LANGUAGES

  • Spanish: Native
  • English: Bilingual
  • Portuguese: Intermediate Level
  • French: Basic Level

WORK EXPERIENCE
CENTRAL AMERICAN RESEARCH UNITED (CARU)
Founder and President 2023-Present

Coordinating, establishing, and overseeing clinical research centers in El Salvador, Costa Rica, and Guatemala.
Building relationships with researchers, medical institutions, sponsors of clinical studies, and regulatory agencies.
Developing and implementing operational policies and procedures to ensure efficiency, quality, and ethical standards in clinical trial management.

ZEPEDA RESEARCH
Chief Medical and Executive Officer 2008-Present

Principal investigator responsible for planning, logistics, and development of clinical research protocols.
Supervising the execution of clinical trials, including patient recruitment and follow-up, as well as data collection.
Ensuring the quality and integrity of clinical data by adhering to Good. Clinical Practice standards (ICH-GCP) and other regulatory requirements.

ZEPEDA DERMATOLOGY
Medical Director 2005-Present

Extensive experience in providing quality dermatological healthcare, with a focus on personalized care and comprehensive management of patients’ skin needs, providing precise diagnoses, dermatological surgery procedures, cosmetic facial rejuvenation procedures, and evidence-based treatments.

UNIVERSITY PROFESSOR
Head of the Dermatology Department at Nueva San Salvador University
2018-2020

Supervising, coordinating, and teaching the dermatology subject at the university, ensuring comprehensive education for medical students in the dermatological field.

EDUCATION

Imagen de la Universidad Francisco Marroquín

UNIVERSIDAD FRANCISCO MARROQUÍN
Dermatologist 2001-2004

Imagen de la Universidad Evangélica de El Salvador

UNIVERSIDAD EVANGÉLICA DE EL SALVADOR
Doctor in Medicine 1992-2001

 

MEDICAL ASSOCIATIONS

ASOCIACIÓN DE PROFESIONALES MEDICOS DE LA DERMATOLOGÍA (PRODERMA)
Founding Member, President of the association in 2016

COLEGIO IBEROAMERICANO DE DERMATOLOGÍA (CILAD)
Member

ASOCIACIÓN DERMATOLÓGICA DE EL SALVADOR
Member

SOCIEDAD CENTROAMERICANA DE DERMATOLOGÍA
Member

SOCIEDAD LATINOAMÉRICANA DE PSORIASIS
Member

CONDUCTED CLINICAL TRIALS

Imagen de la Universidad Francisco Marroquín

 A randomized, observer-blinded, placebo-controlled study on the safety and efficacy of twice-daily application of SM-030 Gel 0.64% vs. Gel SM-030 0.08% vs. Placebo Gel in adults with melasma. Dermbiont Inc. Phase III. 2024-present.

Imagen de la Universidad Francisco Marroquín

Safety and efficacy of Fusidic acid in patients with secondary skin infections. Taro Pharm, Phase IV. 2023.

Imagen de la Universidad Francisco Marroquín

 Adaptive open-label design study to explore the Safety and Efficacy of multiple treatment regimens with Akt Inhibitor SM-020 Gel in 1.0% and 0.1% formulations in subjects with seborrheic keratosis. Dermbiont Inc. Phase III. 2021-present.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of twice-daily application o Ruboxistaurin Gel vs. Vehicle Gel vs. Hydroquinone Cream in sun-exposed and sun-protected skin of adults. DermBiont, Inc. Phase IIA. 2022-2023.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of SCD-044 in the treatment of moderate to severe atopic dermatitis. Taro Pharm, Phase IIB. 2022-present.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of SCD-044 in the treatment of moderate to severe psoriasis. Taro Pharm, Phase IIB. 2022-present.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of Mupirocin in secondary infections by Taro Pharm Phase III 2018-2019. (FDA Audit on 4th November to 9th November, 2019, Satisfactory result, no finding 483).

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of Fusidic acid in patients with Impetigo. Novum Pharm. Phase III. 2018-2019.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of Ivermectin in patients with Pediculosis. Novum Pharm. Phase III. 2018 Safety and Efficacy of Desoximetasone in Atopic Dermatitis. Novum Pharm. PK Study. 2017-2019.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of Desoximetasone in Pediatric Psoriasis. Novum Pharm. PK Study. 2017-2019.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of permethrin in patients with scabies. Novum Pharm. Phase III 2015-2016.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of Favipiravir in patients with Influenza. PPD. Phase III 2013-2015.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of Mupirocin in secondary infections. Novum Pharma. Phase III 2011.

Imagen de la Universidad Francisco Marroquín

Safety and Efficacy of Isotretinoin in acne (Isoface) phase IV Procaps. 2006.

 

CERTIFICATIONS

Imagen de la Universidad Francisco Marroquín

Good Clinical Practices (GCP) NIDA Clinical Trials Network. May 2024 Certificate valid until May 2027.

Imagen de la Universidad Francisco Marroquín

Good Clinical Practices (GCP) NIDA Clinical Trials Network. 2021-2024.

Imagen de la Universidad Francisco Marroquín

Protecting Human Research Participants Training. National Institute of Health 2013.
IATA Certification Mayo Clinic, Mayo Medical Laboratories 2013.

Imagen de la Universidad Francisco Marroquín

Transporting Dangerous Goods, Mayo Clinic; Mayo Medical Laboratories. Certification for the State of Florida and California 2013.

Imagen de la Universidad Francisco Marroquín

First Presencial Course of Good Clinical Practices in Investigation CIDAL- Colegio Médico de El Salvador 2012.